Cost of opioid-related adverse drug events in surgical patients

Journal of Pain and Symptom Management

Volumn 25, Issue 3, 2003, Pages 276-283

  Oderda, Gary M ^a,e   Evans, R Scott ^a,b,d   Lloyd, James ^b   Lipman, Arthur ^a   Chen, Connie ^c   Ashburn, Michael ^a   Burke, John ^a,b   Samore, Matthew ^a  

^a UNIVERSITY OF UTAH   (United States)

^b LDS HOSPITAL   (United States)

^c PFIZER INC   (United States)

^d INTERMOUNTAIN HEALTHCARE   (United States)

^e UNIVERSITY OF UTAH   (United States)

Author keywords

Adverse events; Opioids; Pain; Pharmacoeconomics

Indexed keywords

OPIATE;

ADULT; AGE; AGED; ARTICLE; AUTOMATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; FEMALE; GENDER; HEALTH CARE COST; HOSPITAL COST; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NAUSEA; PREDICTION; PRURITUS; RASH; SKIN MANIFESTATION; SURGICAL PATIENT; URTICARIA; VOMITING;

EID: 0037333345     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(02)00691-7     Document Type: Article

References (15)

1. Committee on Quality of Health Care in America, Institute of Medicine. To Err is Human - Building a Safer Health System. Washington, DC; National Academy Press, 2000.
2. Lazarou J., Pomeranz B.H., Corey P.N. Incidence of adverse drug reactions in hospitalized patients. a meta-analysis of prospective studies JAMA. 279(15):1998;1200-1205.
3. Acute Pain Management Guideline Panel. Acute Pain Management: Operative or Medical Procedures and Trauma; Clinical Practice Guideline. AHCPR Publication Number 92-0032, Rockville MD, Agency for Health Care Policy and Research, U.S. Department of Health and Human Services, Public Health Service, 1992.
4. American Pain Society Principles of analgesic use in the treatment of acute and cancer pain. 4th ed:1999;American Pain Society, Glenbrook, IL.
5. Bates D.W., Spell N., Cullen D.J.et al. The cost of adverse drug events in hospitalized patients. JAMA. 277(4):1997;307-311.
6. Classen D.C., Pestotnik S.L., Evans R.S.et al. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA. 277:1997;301-306.
7. Thomas E.J., Studdert D.M., David M.et al. Costs of medical injuries in Utah and Colorado. Inquiry. 36:1999;255-264.
8. Pryor T.A., Gardner R.M., Clayton P.D., Warner H.R. The HELP system. J Med Sys. 7:1983;87-102.
9. Naranjo C.A., Busto U., Sellers E.M.et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 30:1981;239-245.
10. List of Diagnosis Related Groups (DRGs) - 1999. http://www.hcfa.gov/stats/medpar/drg99dsc.xls.
11. Standard Cost Manager: User's Guide, Cleveland, Ohio: Ernst and Whinney, Intermountain Health Care Inc., 1987.
12. Littell R.C., Milliken G.A., Stroup W.W., Wolfinger R.D. SAS(R) System for Mixed Models. 1996;SAS Institute Inc. Cary, NC.
13. Stata Corporation, 4905 Lakeway Drive, College Station, TX 77845, www.stata.com.
14. SAS Institute Inc., SAS Campus Drive Cary, NC 27513-2414, USA. www.sas.com.
15. Zhou X.H., Melfi C.A., Hui S.L. Methods for comparison of cost data. Ann Intern Med. 127(8 Pt 2):1997;752-756.